Search

Salt Lake City, Utah-based ZARs, a provider of drug delivery products for the pharmaceutical industry, said in a filing with the SEC Friday that it is withdrawing its IPO. The firm, which was looking to sell 5 million shares of its stock at between $14.00 and $16.00 per share, said that it was withdrawing the IPO due to market conditions. As part of its request for withdrawal of its IPO, ZARS also said that it may undertake a private offering. ZARS had filed for an IPO in June. The firm is backed by Draper Fisher Jurvetson, Wasatch Ventures, and vSpring Capital.
posted on Monday, October 8, 2007

Related companies:
Zars

Related stories:
> ZARS In Agreement With Endo Pharmaceuticals
> ZARS Sets IPO Terms
> Zars Files For IPO
> ZARS Gets FDA Approval
> ZARS Expands Board

---

Techrockies.com Home